About us

“VIRTUALMAN is Taiwan’s leading AI-native drug discovery company, specializing in reviving abandoned preclinical drug assets through ADMET/PK optimization, lead compound generation, and proprietary synthesizability prediction.

At the core of our approach is the “New Drug Revival Engine” — a business model that re-optimizes high-potential assets abandoned due to ADMET/PK issues and transforms them into licensable drug candidates. This model has been validated through collaboration with DCB (Development Center for Biotechnology).